← Back to Krishna Institute of Medical Sciences Ltd. overview
Krishna Institute of Medical Sciences Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹3,004 cr | ₹385 cr | ₹9.61 | ₹5,736 cr | ₹2,138 cr | 17.99% | 13.78% | 1.2x | 12.8% |
| FY2024 | ₹2,474 cr | ₹310 cr | ₹7.75 | ₹3,852 cr | ₹1,828 cr | 16.96% | 15.89% | 0.74x | 12.53% |
| FY2023 | ₹2,168 cr | ₹336 cr | ₹8.41 | ₹2,941 cr | ₹1,670 cr | 20.14% | 21.9% | 0.41x | 15.52% |
| FY2022 | ₹1,651 cr | ₹333 cr | ₹8.38 | ₹1,907 cr | ₹1,387 cr | 23.98% | 28.77% | 0.18x | 20.15% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.